Lung transplantation is accepted as a well‐established and effective treatment for patients
with end‐stage lung disease. While the number of candidates added to the waitlist continues …

Background: Use of lungs donated after circulatory death (DCD) has expanded, but changes
in donor/recipient characteristics and comparison to brain dead donors (DBD) has not been …

Objectives: To summarize waitlist and transplant outcomes in kidney, liver, lung, and heart
transplantation using organ donation after circulatory death (DCD). Background: DCD has …

Thoracoabdominal normothermic regional perfusion (TA-NRP) has recently begun being
utilized in the United States for recovery of cardiothoracic allografts from some donors after …

Lung transplantation (LTx) has become a standard therapy with growing activity over the
years that improves the quantity and the quality of life for selected patients suffering from end …

Controlled donation after circulatory death (DCD) has the potential to substantially increase
the number of lung transplants thus offsetting some of the imbalance between need and …

Objective Ex vivo lung perfusion has emerged as a novel technique to safely preserve lungs
before transplantation. Recent studies have demonstrated an accumulation of inflammatory …

Objective Ex vivo lung perfusion (EVLP) allows for prolonged preservation and evaluation/
resuscitation of donor lungs. We evaluated the influence of center experience with EVLP on …

Thoracoabdominal normothermic regional perfusion has emerged as an alternative method
to procure donation after circulatory death (DCD) hearts, but its impact on concomitantly …

Standard physiologic assessment parameters of donor lung grafts may not accurately reflect
lung injury or quality. A biometric profile of ischemic injury could be identified as a means to …